Ikarian Capital, LLC Biovie Inc. Transaction History

Ikarian Capital, LLC

  • $754 Million
  • Q1 2024

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2023

Nov 14, 2023
BUY
$2.75 - $5.17 $24,169 - $45,439
8,789 Added 1.96%
457,345 $1.56 Million
Q2 2023

Aug 14, 2023
BUY
$4.09 - $8.29 $409,000 - $828,999
100,000 Added 28.69%
448,556 $1.93 Million
Q1 2023

May 15, 2023
BUY
$4.89 - $10.53 $1.7 Million - $3.67 Million
348,556 New
348,556 $2.82 Million

Others Institutions Holding BIVI

# of Institutions
57
Shares Held
7M
Call Options Held
51.7K
Put Options Held
353K
View Full List

About BIOVIE INC.

BIVI Quotes by TradingView
  • Ticker BIVI
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 30,165,300
  • Market Cap $12.1M
  • Description
  • BioVie Inc., a clinical stage biotechnology company, engages in the discovery, development, and commercialization of drugs therapies in the United States. Its products in pipeline include BIV201, which completed Phase IIa clinical trial for the treatment of ascites due to chronic liver cirrhosis; and NE3107, which is in Phase III clinical trial ...
More about BIVI
Track This Portfolio

Track Ikarian Capital, LLC Portfolio

Follow Ikarian Capital, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Ikarian Capital, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Ikarian Capital, LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email